Última actualización 12 de julio de 2026
Key finding
Glycemic outcomes attained were similar to commercial AID systems.
AndroidAPS, an open-source automated delivery system, in adults with type 1 diabetes.
Quick read
The essential study design details in one scan.
EvidenceScore™
Moderate
Study type
RCTs
Follow-up
Short-Term (≤3 mo)
Risk of bias
Some Concerns
Guarda investigacion, organiza estudios y vuelve a encontrar evidencia importante rapidamente.
Plain-language summary
A plain-language read of the study’s main message and where it applies.
Study focus
AndroidAPS, an open-source automated delivery system, in adults with type 1 diabetes.
This study evaluated AndroidAPS, an open-source automated delivery system, in adults with type 1 diabetes.
Limitations were not clearly described in the extracted text.
Published in
Publication details and source links for this paper.
Tom MW, Martin DB. Assessing the Glycemic Efficacy and Safety of AndroidAPS in Adults with Type 1 Diabetes. Journal of Diabetes Science and Technology. 2023;18(4):897-898. doi:10.1177/19322968231208216
Evidence network
Understand where this research contributes within the broader evidence network.
This study contributes evidence to AndroidAPS - Treatment A and Glycemic control comparison to commercial AID systems, Safety events.
This study contributes evidence to
Primary intervention
AndroidAPS - Treatment A
Primary outcomes
Primary intervention
Intervention and outcome relationships this study adds to the evidence network.
Editorial context
See why this paper is useful beyond its individual results.
Evidence network role
This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.
0
Related topics
2
Evidence pairs
0
Related studies
Core evidence
The primary outcomes reported in this study.
AndroidAPS - Treatment A → Glycemic control comparison to commercial AID systems
AndroidAPS - Treatment A → Glycemic control comparison to commercial AID systems
Evidence Library
Save research, organize studies, and quickly find important evidence again.
Evidence Library
Save research, organize studies, and quickly find important evidence again.
Explore related studies, evidence collections, and research questions.
Relationships organized using the Dediabetes Evidence Intelligence™ framework.
This study contributes to evidence on AndroidAPS - Treatment A and Glycemic control comparison to commercial AID systems, AndroidAPS - Treatment A and Safety events.
This study contributes to the evidence on the following intervention-outcome relationships.
Devices & Technology
Devices & Technology
Curated evidence collections and hubs this study is part of.
All studies on AndroidAPS - Treatment A
Contributes to AndroidAPS - Treatment A evidence base.
All studies measuring Glycemic control comparison to commercial AID systems
Measures Glycemic control comparison to commercial AID systems as a key outcome.
All studies measuring Safety events
Measures Safety events as a key outcome.
Jump to pre-filtered views in Evidence Explorer.
1 results
1 results
1 results
1 results
1 results
Generated from the study's connected evidence using Evidence Intelligence™.
AndroidAPS - Treatment A appears to improve Glycemic control comparison to commercial AID systems.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Glycemic control comparison to commercial AID systems
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Current evidence does not show a clear benefit of AndroidAPS - Treatment A for Safety events.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Safety events
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Next steps
Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.
Open broader Evidence Explorer views for this relationship.
Read related research summaries.
Focused on evidence, not advertising.
Your data is always protected.
New studies added every day.
